Page 58 - GPD-3-1

Gene & Protein in Disease Prognostic potential of LMNB2 in LPS

References 12. Dechat T, Adam SA, Goldman RD. Nuclear lamins and
chromatin: When structure meets function. Adv Enzyme
1. Cissé MY, Pyrdziak S, Firmin N, et al. Targeting MDM2- Regul. 2009;49(1):157-166.
dependent serine metabolism as a therapeutic strategy for
liposarcoma. Sci Transl Med. 2020;12(547):eaay2163. doi: 10.1016/j.advenzreg.2008.12.003
doi: 10.1126/scitranslmed.aay2163 13. Capell BC, Collins FS. Human laminopathies: Nuclei gone
genetically awry. Nat Rev Genet. 2006;7(12):940-952.
2. Lee ATJ, Thway K, Huang PH, Jones RL. Clinical and
molecular spectrum of liposarcoma. J Clin Oncol. doi: 10.1038/nrg1906
2018;36(2):151-159. 14. Worman HJ, Bonne G. “Laminopathies”: A wide spectrum
doi: 10.1200/jco.2017.74.9598 of human diseases. Exp Cell Res. 2007;313(10):2121-2133.
doi: 10.1016/j.yexcr.2007.03.028
3. Choi JH, Ro JY. The 2020 WHO classification of tumors
of soft tissue: Selected changes and new entities. Adv Anat 15. Guinde J, Frankel D, Perrin S, et al. Lamins in lung cancer:
Pathol. 2021;28(1):44-58. Biomarkers and key factors for disease progression through
miR-9 regulation? Cells. 2018;7(7):78.
doi: 10.1097/pap.0000000000000284
doi: 10.3390/cells7070078
4. Haddox CL, Riedel RF. Recent advances in the understanding
and management of liposarcoma. Fac Rev. 2021;10:1. 16. Kong W, Wu Z, Yang M, Zuo X, Yin G, Chen W. LMNB2
is a prognostic biomarker and correlated with immune
doi: 10.12703/r/10-1
infiltrates in hepatocellular carcinoma. IUBMB Life.
5. Creytens D, Folpe AL, Koelsche C, et al. Myxoid pleomorphic 2020;72(12):2672-2685.
liposarcoma-a clinicopathologic, immunohistochemical, doi: 10.1002/iub.2408
molecular genetic and epigenetic study of 12 cases, suggesting
a possible relationship with conventional pleomorphic 17. Prasad S, Soldatenkov VA, Srinivasarao G, Dritschilo A.
liposarcoma. Mod Pathol. 2021;34(11):2043-2049. Intermediate filament proteins during carcinogenesis and
apoptosis (Review). Int J Oncol. 1999;14(3):563-570.
doi: 10.1038/s41379-021-00862-2
doi: 10.3892/ijo.14.3.563
6. Crago AM, Dickson MA. Liposarcoma: Multimodality
management and future targeted therapies. Surg Oncol Clin 18. Monier B, Suzanne M. Orchestration of force generation
N Am. 2016;25(4):761-773. and nuclear collapse in apoptotic cells. Int J Mol Sci.
2021;22(19):10257.
doi: 10.1016/j.soc.2016.05.007
doi: 10.3390/ijms221910257
7. Yang L, Chen S, Luo P, Yan W, Wang C. Liposarcoma: Advances
in cellular and molecular genetics alterations and corresponding 19. Mu W, Guo L, Liu Y, Yang H, Ning S, Lv G. Long noncoding
clinical treatment. J Cancer. 2020;11(1):100-107. RNA SNHG1 regulates LMNB2 expression by sponging
miR-326 and promotes cancer growth in hepatocellular
doi: 10.7150/jca.36380 carcinoma. Front Oncol. 2021;11:784067.
8. Nassif NA, Tseng W, Borges C, Chen P, Eisenberg B. Recent doi: 10.3389/fonc.2021.784067
advances in the management of liposarcoma. F1000Res.
2016;5:2907. 20. Dong CH, Jiang T, Yin H, et al. LMNB2 promotes the
progression of colorectal cancer by silencing p21 expression.
doi: 10.12688/f1000research.10050.1 Cell Death Dis. 2021;12(4):331.
9. Keung EZ, Akdemir KC, Al Sannaa GA, et al. Increased doi: 10.1038/s41419-021-03602-1
H3K9me3 drives dedifferentiated phenotype via KLF6
repression in liposarcoma. J Clin Invest. 2015;125(8):2965-2978. 21. Robin JD, Magdinier F. Physiological and pathological aging
affects chromatin dynamics, structure and function at the
doi: 10.1172/jci77976 nuclear edge. Front Genet. 2016;7:153.

10. Damiano JA, Afawi Z, Bahlo M, et al. Mutation of the nuclear doi: 10.3389/fgene.2016.00153
lamin gene LMNB2 in progressive myoclonus epilepsy with
early ataxia. Hum Mol Genet. 2015;24(16):4483-4490. 22. Porter AG, Ng P, Jänicke RU. Death substrates come alive.
BioEssays. 1997;19(6):501-507.
doi: 10.1093/hmg/ddv171
doi: 10.1002/bies.950190609
11. Evangelisti C, Rusciano I, Mongiorgi S, et al. The wide 23. Méndez-López I, Blanco-Luquin I, Sánchez-Ruiz de
and growing range of lamin B-related diseases: From Gordoa J, et al. Hippocampal LMNA gene expression is
laminopathies to cancer. Cell Mol Life Sci. 2022;79(2):126.
increased in late-stage Alzheimer’s disease. Int J Mol Sci.
doi: 10.1007/s00018-021-04084-2 2019;20(4):878.

Volume 3 Issue 1 (2024) 12 https://doi.org/10.36922/gpd.2607